+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amphotericin B"

Candidiasis Drugs - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 250 Pages
  • Global
From
Antifungal Drugs - Global Strategic Business Report - Product Thumbnail Image

Antifungal Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 179 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 193 Pages
  • Global
From
Pneumonia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pneumonia Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 100 Pages
  • Global
From
From
From
From
Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Meningitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pulmonary Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pulmonary Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Candidiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Candidiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Otomycosis - Pipeline Insight, 2025 - Product Thumbnail Image

Otomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Leishmaniasis - Pipeline Insight, 2025 - Product Thumbnail Image

Leishmaniasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cryptococcosis - Pipeline Insight, 2025 - Product Thumbnail Image

Cryptococcosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vulvovaginal Candidiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Vulvovaginal Candidiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Candidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Candidemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Topical Skin Infection Treatment Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Topical Skin Infection Treatment Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs. The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more